Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia
- PMID: 12851636
- DOI: 10.1038/sj.mp.4001308
Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia
Abstract
Anatomical and molecular abnormalities of excitatory neurons in the dorsolateral prefrontal cortex (DLPFC) are found in schizophrenia. We hypothesized that brain-derived neurotrophic factor (BDNF), a protein capable of increasing pyramidal neuron spine density and augmenting synaptic efficacy of glutamate, may be abnormally expressed in the DLPFC of patients with schizophrenia. Using an RNase protection assay and Western blotting, we detected a significant reduction in BDNF mRNA (mean=23%) and protein (mean=40%) in the DLPFC of patients with schizophrenia compared to normal individuals. At the cellular level, BDNF mRNA was expressed at varying intensities in pyramidal neurons throughout layers II, III, V, and VI of DLPFC. In patients with schizophrenia; neuronal BDNF expression was decreased in layers III, V and VI. Our study demonstrates a reduction in BDNF production and availability in the DLPFC of schizophrenics, and suggests that intrinsic cortical neurons, afferent neurons, and _target neurons may receive less trophic support in this disorder.
Similar articles
-
Reductions in neurotrophin receptor mRNAs in the prefrontal cortex of patients with schizophrenia.Mol Psychiatry. 2005 Jul;10(7):637-50. doi: 10.1038/sj.mp.4001678. Mol Psychiatry. 2005. PMID: 15940304
-
Changes in alternative brain-derived neurotrophic factor transcript expression in the developing human prefrontal cortex.Eur J Neurosci. 2009 Apr;29(7):1311-22. doi: 10.1111/j.1460-9568.2009.06669.x. Epub 2009 Mar 23. Eur J Neurosci. 2009. PMID: 19519623
-
Analysis of pyramidal neuron morphology in an inducible knockout of brain-derived neurotrophic factor.Biol Psychiatry. 2005 Apr 15;57(8):932-4. doi: 10.1016/j.biopsych.2005.01.010. Biol Psychiatry. 2005. PMID: 15820715
-
Brain-derived neurotrophic factor in schizophrenia and its relation with dopamine.Int Rev Neurobiol. 2007;78:377-95. doi: 10.1016/S0074-7742(06)78012-6. Int Rev Neurobiol. 2007. PMID: 17349867 Review.
-
Brain-derived neurotrophic factor: findings in schizophrenia.Curr Opin Psychiatry. 2011 Mar;24(2):122-7. doi: 10.1097/YCO.0b013e3283436eb7. Curr Opin Psychiatry. 2011. PMID: 21248641 Review.
Cited by
-
Glucocorticoid receptor 1B and 1C mRNA transcript alterations in schizophrenia and bipolar disorder, and their possible regulation by GR gene variants.PLoS One. 2012;7(3):e31720. doi: 10.1371/journal.pone.0031720. Epub 2012 Mar 13. PLoS One. 2012. PMID: 22427805 Free PMC article.
-
MicroRNA expression profiling in the prefrontal cortex of individuals affected with schizophrenia and bipolar disorders.Schizophr Res. 2010 Dec;124(1-3):183-91. doi: 10.1016/j.schres.2010.07.002. Epub 2010 Aug 2. Schizophr Res. 2010. PMID: 20675101 Free PMC article.
-
Promoter specific alterations of brain-derived neurotrophic factor mRNA in schizophrenia.Neuroscience. 2010 Sep 1;169(3):1071-84. doi: 10.1016/j.neuroscience.2010.05.037. Epub 2010 May 27. Neuroscience. 2010. PMID: 20553817 Free PMC article.
-
Brain-Derived Neurotrophic Factor in Brain Disorders: Focus on Neuroinflammation.Mol Neurobiol. 2019 May;56(5):3295-3312. doi: 10.1007/s12035-018-1283-6. Epub 2018 Aug 17. Mol Neurobiol. 2019. PMID: 30117106 Free PMC article. Review.
-
Effects of maternal smoking and exposure to methylmercury on brain-derived neurotrophic factor concentrations in umbilical cord serum.Toxicol Sci. 2010 Oct;117(2):263-9. doi: 10.1093/toxsci/kfq216. Epub 2010 Jul 14. Toxicol Sci. 2010. PMID: 20631062 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical